DGAP-News: Biotest AG: Biotest erhält Genehmigung f

DGAP-News: Biotest AG / Schlagwort(e): Studie Biotest AG: Biotest erhält Genehmigung für klinische Phase III-Studie bei Schwangeren zur Prävention von CMV-Infektionen des ungeborenen Kindes 26.08.2021 / 07:00 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITT...

Related Keywords

Germany , Hanover , Niedersachsen , Munich , Bayern , German , John Biotest , Biotest , S Distribution Services , Ethics Committee , University Tbingen , German Exchange , Study Biotest , Press Release Biotest , Hearing Loss , High Medical Demand , Number Babies , Significant Reduction , Her Applicant , Urgent Necessity , Medical Demand , Infectious Disease , Silke Campaigner , Included Women , Pregnancy Week , Transmission Rate , Control Group , Above Biotest , Transplant Recipients , Value Chain , Areas Of Application Clinical Immunology , Emergency Medicine , Preference Shares , Common Stock , Preferred Share , Free Traffic , Trade Gate This Document , Net Assets , Her Subsidiaries , Factors Of Uncertainty , Publication Validity , Financial Object , Reporting Obligations , Press Releases , Media Archive , German Take , Germany Phone , Regulated Market , Trade Gate , G , Genehmigung , Hase , Ii Studie , Chwangeren , Prävention , Mv Infektionen , Shindes , ür , Nhalt , Itteilung , Mittent , Herausgeber ,